Effects And Safety Of Pueraria Mirifica On Lipid Profiles And Biochemical Markers Of Bone Turnover Rates In Healthy Postmenopausal Women

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 51
Sex n/a
Notes for this study:
Bone specific ALP was reduced in women taking 20-50mg of Pueraria relative to placebo, suggesting improvements to bone health over time (despite bone mineral density not being measured in this study)